Zhi Mou - Immage Biotherapeutics CEO
CEO
Mr. Zhi Cong Mou is President, Chief Executive Officer, Treasurer, Secretary, Director of the Company. He President, Treasurer, Secretary, Director of the Company. He is President . Since March 2012, Mr. Mou was the Accounts Director for Nanning Business Consulting Co., GuanXi, China company engage in the business of account auditing. From June 2009 through February 2012, Mr. Mou worked as the Accounts Manager for Nanning Business Consulting Co. Prior to that, from February 2004 through February 2007, Mr. Mou was an inhouse company accountant for Yongjian Engineering Co., Ltd., a GuanXi, China company engaged in the business of civil construction. since 2015.
| Age | 40 |
| Tenure | 9 years |
| Phone | 866-692-2939 |
| Web | http://www.immagebio.com |
Immage Biotherapeutics Management Efficiency
The company has return on total asset (ROA) of (4.9611) % which means that it has lost $4.9611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.3357) %, meaning that it created substantial loss on money invested by shareholders. Immage Biotherapeutics' management efficiency ratios could be used to measure how well Immage Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CEO Age | ||
| Gaofei Wang | Weibo Corp | 45 | |
Management Performance
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 |
Immage Biotherapeutics Leadership Team
Elected by the shareholders, the Immage Biotherapeutics' board of directors comprises two types of representatives: Immage Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immage. The board's role is to monitor Immage Biotherapeutics' management team and ensure that shareholders' interests are well served. Immage Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immage Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Achinko, VP of Bioformatics | ||
| Mahesh Narayanan, COO and Director | ||
| CPA JD, CFO and Director | ||
| Zhi Mou, CEO and President Treasurer, Secretary and Director |
Immage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Immage Biotherapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 32.93 K | |||
| Shares Outstanding | 151.74 M | |||
| Shares Owned By Insiders | 69.85 % | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.82 M) | |||
| Net Income | (216.48 K) | |||
| Cash And Equivalents | 53.69 K | |||
| Debt To Equity | 2.52 % |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |